APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 27 filers reported holding APTEVO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $515 | -77.0% | 1,562 | +2.0% | 0.00% | – |
| Q2 2023 | $2,235 | -31.9% | 1,531 | -5.1% | 0.00% | – |
| Q1 2023 | $3,284 | -12.2% | 1,614 | +0.1% | 0.00% | – |
| Q4 2022 | $3,742 | -25.2% | 1,613 | -8.0% | 0.00% | – |
| Q3 2022 | $5,000 | 0.0% | 1,754 | +12.5% | 0.00% | – |
| Q2 2022 | $5,000 | -44.4% | 1,559 | +0.3% | 0.00% | – |
| Q1 2022 | $9,000 | -25.0% | 1,555 | 0.0% | 0.00% | – |
| Q4 2021 | $12,000 | -50.0% | 1,555 | +0.2% | 0.00% | – |
| Q3 2021 | $24,000 | -31.4% | 1,552 | -0.1% | 0.00% | – |
| Q2 2021 | $35,000 | -25.5% | 1,554 | +0.1% | 0.00% | – |
| Q1 2021 | $47,000 | -17.5% | 1,553 | +0.1% | 0.00% | – |
| Q4 2020 | $57,000 | +1800.0% | 1,552 | +241.1% | 0.00% | – |
| Q3 2020 | $3,000 | -25.0% | 455 | +1.1% | 0.00% | – |
| Q2 2020 | $4,000 | – | 450 | +1700.0% | 0.00% | – |
| Q1 2020 | $0 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,760,000 | $39,477,000 | 7.86% |
| RTW INVESTMENTS, LP | 281,402 | $6,312,000 | 0.10% |
| KENNEDY CAPITAL MANAGEMENT LLC | 187,995 | $4,217,000 | 0.09% |
| Anson Funds Management LP | 35,587 | $798,000 | 0.08% |
| Alyeska Investment Group, L.P. | 139,172 | $3,122,000 | 0.04% |
| Dynamic Technology Lab Private Ltd | 14,022 | $315,000 | 0.03% |
| JBF Capital, Inc. | 3,907 | $88,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 15,350 | $344,000 | 0.01% |
| Renaissance Technologies | 159,923 | $3,587,000 | 0.00% |
| QS Investors, LLC | 15,650 | $352,000 | 0.00% |